Parker Jenkins
Founder of Adialante, Cancer screening without barriers
Company
Parker Jenkins is listed as a founder of Adialante. We know how to improve cancer outcomes by 8x-10x: you catch it early. MRI is the most robust and powerful cancer-detection tool in the world, yet systems cost millions to purchase, take months to install, and require high levels of technical skill to operate. We've redesigned MRI from the ground up with new physics, algorithms, and hardware, all to bring cancer screening to the entire world. Our mobile MRI is an imaging clinic on wheels. No equipment to buy, no infrastructure needed. For a flat per-scan fee, any medical site can offer MRI cancer screening. Starting with prostate cancer. Then everything else.
Founder traction evidence
Public posts and activity attributed directly to this founder.
- LinkedIn
On February 20th, we got a call that changed our trajectory. We're thrilled to finally announce it. Adialante is now a part of the Y Combinator P26 Cohort! MRI is an incredibly powerful diagnostic tool. With it, we can detect cancers early enough to save lives. But today, clinically valuable MRI is out of reach. Adialante is changing that. We're making MRI accessible enough for any of us to get screened before it's too late. Since getting the call, we've kicked into high gear. We don't take this opportunity lightly. We will make it count. When Adialante's story is fully written, early cancer detection won't be a privilege dictated by geography or income. YC's support will be a big reason why. 🥂 Here's to the work ahead and to all the unsung heroes and supporters who brought us to this moment. And to our incredible team: Efraín Torres, PhD, Parker Jenkins, Michael Mullen, Sai Abitha Srin
On February 20th, we got a call that changed our trajectory. We're thrilled to finally announce it. Adialante is now a part of the Y Combinator P26 Cohort! MRI is an incredibly powerful diagnostic tool. With it, we can detect cancers early enough to save lives. But today,...